Precision Medicine Initiative (United States)

Precision Medicine Initiative (United States)
Name	Precision Medicine Initiative (United States)
Established	2015
Founder	Barack Obama
Location	United States

Precision Medicine Initiative (United States) The Precision Medicine Initiative (United States) is a federal research effort announced in 2015 to accelerate biomedical research and tailor medical care using individual variability. It was proposed by Barack Obama and coordinated through agencies including the National Institutes of Health, Food and Drug Administration, and Centers for Disease Control and Prevention with collaborations across academia, industry, and patient advocacy groups. The initiative sought to integrate genomic, environmental, and lifestyle data to inform prevention and treatment strategies for diseases such as cancer, diabetes mellitus, and Alzheimer's disease.

Background and Objectives

The initiative built on prior programs such as the Human Genome Project, the All of Us Research Program, and the Cancer Moonshot to pursue precision approaches in clinical care and public health, aligning interests of institutions like National Cancer Institute, National Human Genome Research Institute, and Howard Hughes Medical Institute. Its objectives included creating a large cohort for longitudinal study, promoting translational research among entities like Mayo Clinic, Johns Hopkins University, and Massachusetts Institute of Technology, and enabling data sharing consistent with standards from World Health Organization, Institute of Medicine, and Office of the National Coordinator for Health Information Technology.

Launch and Key Participants

Announced by Barack Obama at the State of the Union Address, the initiative enlisted leadership from Francis Collins, Sylvia Burwell, and agencies such as National Institutes of Health, Food and Drug Administration, and Centers for Medicare & Medicaid Services, while partnering with private-sector firms including Google, IBM, 23andMe, and Foundation Medicine. Academic participants included Harvard University, Stanford University, University of California, San Francisco, and Columbia University, with patient organizations like Alzheimer's Association, American Cancer Society, and American Diabetes Association contributing to recruitment and governance.

Research Components and Programs

Core programs encompassed cohort development exemplified by the All of Us Research Program, genomic initiatives referencing technologies from Illumina and Pacific Biosciences, and disease-focused efforts echoing the Cancer Moonshot and the BRAIN Initiative. Complementary projects included biomarker discovery coordinated with European Molecular Biology Laboratory, computational efforts leveraging platforms from Amazon Web Services and Microsoft Azure, and clinical trials partnerships with organizations such as National Cancer Institute and ClinicalTrials.gov. Cross-disciplinary collaborations involved laboratories at Cold Spring Harbor Laboratory, consortia like the Global Alliance for Genomics and Health, and registries modeled on Framingham Heart Study.

Data Infrastructure and Privacy Framework

Data infrastructure combined electronic health record integration informed by Epic Systems and Cerner Corporation, cloud computing from Amazon Web Services and Google Cloud Platform, and standards from Health Level Seven International and Fast Healthcare Interoperability Resources. Privacy and governance frameworks referenced laws and agencies including Health Insurance Portability and Accountability Act, Common Rule, Office for Civil Rights, and guidance from President's Commission for the Study of Bioethical Issues and National Academy of Medicine. The initiative employed consent models influenced by protocols at Johns Hopkins University, data access committees similar to those at dbGaP, and security practices aligned with National Institute of Standards and Technology.

Funding, Policy, and Legislation

Initial funding was proposed in the United States federal budget and supported through appropriations involving committees such as the United States House Committee on Appropriations and United States Senate Committee on Appropriations, with oversight by Congress of the United States and executive agencies including Office of Management and Budget. Legislative touchpoints included debates related to 21st Century Cures Act and policy coordination with Centers for Medicare & Medicaid Services for reimbursement models that engaged stakeholders like American Medical Association and Blue Cross Blue Shield Association.

Scientific Outcomes and Impact

Scientific outputs included large-scale genomic datasets contributing to research at National Institutes of Health, translational findings applied in oncology at centers such as Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, and methodological advances in computational biology used by groups at Broad Institute and Sanger Institute. The initiative influenced precision oncology trials registered on ClinicalTrials.gov, polygenic risk score research at University of Cambridge, and implementation studies in health systems like Kaiser Permanente, informing practice guidelines from organizations such as American College of Physicians and American Society of Clinical Oncology.

Criticism and Ethical Concerns

Critics from entities like American Civil Liberties Union, bioethicists at Georgetown University, and commentators in outlets such as The New York Times raised concerns about privacy under Health Insurance Portability and Accountability Act, potential discrimination under Genetic Information Nondiscrimination Act, consent models debated by Presidential Commission for the Study of Bioethical Issues, and equity in representation highlighted by researchers at Howard University and University of Puerto Rico. Additional critiques focused on commercial partnerships involving companies like 23andMe and Google and potential conflicts noted by watchdogs such as Government Accountability Office.

Category:Medical research initiatives in the United States